ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013

Similar documents
Stratégie et action européennes

Stratégies et actions au niveau européen et international: populations humaines

AMR epidemiological situation: ECDC update

European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe

European Antibiotic Awareness Day

Antimicrobial resistance and antimicrobial consumption in Europe

The threat of multidrug-resistant microorganisms and how to deal with it in Europe

What is the problem? Latest data on antibiotic resistance

Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices

Antimicrobial resistance (EARS-Net)

Summary of the latest data on antibiotic consumption in the European Union

Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe

Summary of the latest data on antibiotic resistance in the European Union

Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report

Summary of the latest data on antibiotic consumption in the European Union

Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector

The European road map against antimicrobial resistance

Politique du bon usage des antibiotiques: état des lieux et perspectives en Europe

European challenges on antimicrobial resistance from a one health perspective Danish EU Presidency meeting, Copenhagen, 14 March 2012

How is Ireland performing on antibiotic prescribing?

The challenge of growing resistance

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

EFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA

AMR situation in Europe: Strategy and vision

ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials

European Medicines Agency role and experience on antimicrobial resistance

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

Quelle politique antibiotique pour l Europe? Dominique L. Monnet

The European AMR Challenge - strategic views from the human perspective -

ECDC country visit to Luxembourg to discuss antimicrobial resistance issues

MISSION REPORT. ECDC country visit to Spain to discuss antimicrobial resistance issues February

COMMISSION OF THE EUROPEAN COMMUNITIES

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

Surveillance of AMR in PHE: a multidisciplinary,

Prof. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons

Evaluation of EU strategy to combat AMR

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

Update on European Agencies activities in the field of AMR

MISSION REPORT. ECDC country visit to Malta to discuss antimicrobial resistance issues. 3-7 July

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

Antibiotics and resistance in the WHO Regional Office for Europe. Dr Nienke van de Sande On behalf of the AMR Working Group

Stop overuse of antibiotics in humans rational use

MISSION REPORT. ECDC country visit to Belgium to discuss antimicrobial resistance issues November

Antimicrobial Stewardship. Where are we now and where do we need to go?

Antibiotic resistance: the rise of the superbugs

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The

Antimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries

EFSA s activities on Antimicrobial Resistance

W O s trategi g c i actio i n o n pl p a l n n on o ant n ib i i b o i t o ic i resis i tanc n e in i n Eu E r u op o e p

German Antimicrobial Resistance Strategy DART 2020

The Commission activities on AMR (focus on zoonotic issues)

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Antimicrobial consumption

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)

Antimicrobial consumption

MISSION REPORT. ECDC country visit to Italy to discuss antimicrobial resistance issues January

Governance e sostenibilità nell antibioticoterapia. Anna Maria Cattelan UOC Malattie Infettive Azienda Ospedaliera Universitaria Padova

Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist

Measures relating to antimicrobial resistance (AMR)

Consumption of antibiotics in hospitals. Antimicrobial stewardship.

Quality indicators and outcomes in the devolved nations Scotland

EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.

Use of Antibiotics in Animals. A European Perspective by a Dutch observer. Dr. Albert Meijering

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

ESVAC (European Surveillance of Veterinary Antimicrobial Consumption)

Antimicrobial resistance and the need for stewardship. Dr Nick Brown RCP Acute Medicine conference, 16 April 2018

COMBATING ANTIMICROBIAL RESISTANCE TIME FOR JOINT A CTION

Antimicrobial Stewardship in Scotland

Antimicrobial Resistance Update for Community Health Services

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

MISSION REPORT. ECDC country visit to Norway to discuss antimicrobial resistance issues March

Anne Santerre Henriksen- Florence February 17th

Global action plan to combat antimicrobial resistance (AMR)

COMMISSION STAFF WORKING DOCUMENT. Evaluation of the Action Plan against the rising threats from antimicrobial resistance

How to get senior hospital and clinical engagement

WHO global and regional activities on AMR and collaboration with partner organisations

Antibiotic Stewardship in Human Health- Progress and Opportunities

Promoting Appropriate Antimicrobial Prescribing in Secondary Care

The South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa

Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

ANTIMICROBIAL STEWARDSHIP IN SCOTLAND. Key achievements of the Scottish Antimicrobial Prescribing Group

ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT

Antimicrobial Resistance and Papua New Guinea WHY is it important? HOW has the problem arisen? WHAT can we do?

WELSH HEALTH CIRCULAR

EU strategy to fight against Antimicrobial Resistance

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Antimicrobial Stewardship: The South African Perspective

How do people obtain antibiotics in European countries: an overview

Physician Rating: ( 23 Votes ) Rate This Article:

Optimizing use of quality antimicrobial medicines in humans

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

Antimicrobial Stewardship

Transcription:

ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013

What is the European Union? 27 Member States 24 official languages > 500 million inhabitants (per country: 420,000 81.8 million) 25,200 GDP/capita (per country : 4,800 82,700) A patchwork of cultures! Source: Eurostat, 2012.

Healthcare resources in the EU %GDP for healthcare: approx. 6 to 11% Physicians: 27 to 200 per 100,000 inh. Nurses: 327 to 1550 per 100,000 inh. Source: WHO Health For All online database.

Europe: cultural differences, but a healthy culture of benchmarking! Who makes fun of whom in Europe? Adapted from: Helsingin Sanomat, Finland

Healthcare-associated infections, antimicrobial resistance: Overlapping, but not identical Healthcareassociated infections Antimicrobial resistance Community-acquired infections

Antimicrobial Resistance and Healthcare- Associated Infections (ARHAI) Programme EARS-Net ESAC-Net HAI-Net Coordination Coordination Group Coordination Group CG + Business Meet. Joint Meeting of ARHAI Networks Ongoing surveillance Epidemic intelligence Interactive database Interactive database & Annual report & Annual report Inter-agency report (2013) EPIS AMR-HAI Interactive database & Reports EPIS AMR-HAI Point prevalence survey Point prevalence survey of HAI and antimicrobial use in acute care hospitals Indicators Antibiotic stewardship indicators Infection control indicators Ad-hoc studies / projects Carbapenemase survey (2013) HALT-2 C. difficile surv. Risk assessment : syst. reviews and guidance Carbapenemaseproducing Enterobacteriaceae Perioperative proph. & Antibiotic stewardship prog. Infection control prog. Communication European Antibiotic Awareness Day Contribution to WHO Hand Hygiene Day Training Short course on prevention and control of MDROs Infection control training needs

http://ecdc.europa.eu/en/activities/diseaseprogrammes/arhai/pages/index.aspx

Antimicrobial resistance A threat to patient safety Limited options for for treatment Each year, in EU/EAA: 2.5 million attributable extra hospital days Increased length Increased of length of hospital stays hospital stays 25,000 attributable deaths Increased patient morbidity and mortality Increased patient morbidity and mortality Source: ECDC, 2009. In: http://ecdc.europa.eu/en/publications/publications/0909_ter_the_bacterial_challenge_time_to_react.pdf

European Antimicrobial Resistance Surveillance Network (EARS-Net) Since 1999, as the European Antimicrobial Resistance Surveillance System (EARSS) financed by grants from the European Commission (DG SANCO) to the Dutch National Institute for Public Health and the Environment (RIVM), followed by a grant from ECDC until December 2009 Coordinated by ECDC since January 2010 27 EU Member States, Iceland and Norway Microbiology and epidemiology contact points in each country Coordination Group (European experts) Annual report (at ECDC: 2009, 2010, 2011) Interactive database (ECDC website) http://ecdc.europa.eu/en/activities/surveillance/ears-net/pages/index.aspx

Antimicrobial resistance in Europe, 2011: percentage of invasive isolates showing resistance Staphylococcus aureus, meticillin resistance (MRSA) Klebsiella pneumoniae, combined resistance* * Combined resistance: resistance to third-generation cephalosporins, fluoroquinolones and aminoglycosides Source: EARS-Net, 2012 The symbols and indicate a significant increasing or decreasing trend for the period 2008-2011, respectively. These trends were calculated on laboratories that consistently reported during 2008-2011.

Staphylococcus aureus: percentage of invasive isolates resistant to meticillin (MRSA); EU/EEA, 2008 2011 2008 2011 Source: EARS-Net, 2012 The symbols and indicate a significant increasing or decreasing trend for the period 2008-2011, respectively. These trends were calculated on laboratories that consistently reported during 2008-2011.

Escherichia coli: percentage of invasive isolates resistant to third-generation cephalosporins; EU/EEA, 2008 2011 2008 2011 Source: EARS-Net, 2012 The symbols and indicate a significant increasing or decreasing trend for the period 2008-2011, respectively. These trends were calculated on laboratories that consistently reported during 2008-2011.

Escherichia coli: percentage of invasive isolates resistant to fluoroquinolones; EU/EEA, 2008-2011 2008 2011 Source: EARS-Net, 2012 The symbols and indicate a significant increasing or decreasing trend for the period 2008-2011, respectively. These trends were calculated on laboratories that consistently reported during 2008-2011.

Klebsiella pneumoniae: percentage of invasive isolates with combined resistance*; EU/EEA, 2008 2011 2008 2011 *Combined resistance: resistance to third-generation cephalosporins, fluoroquinolones and aminoglycosides Source: EARS-Net, 2012 The symbols and indicate a significant increasing or decreasing trend for the period 2008-2011, respectively. These trends were calculated on laboratories that consistently reported during 2008-2011.

Klebsiella pneumoniae: percentage of invasive isolates resistant to carbapenems; EU/EEA, 2008 2011 2008 2011 Source: EARS-Net, 2012 The symbols and indicate a significant increasing or decreasing trend for the period 2008-2011, respectively. These trends were calculated on laboratories that consistently reported during 2008-2011.

European Surveillance of Antimicrobial Consumption (ESAC-Net) Since 2001, as the European Surveillance of Antimicrobial Consumption (ESAC) project financed by grants from the European Commission (DG SANCO) to the University of Antwerp, followed by grants from ECDC until June 2011 Coordinated by ECDC since July 2011 27 EU Member States, Iceland and Norway Contact points in each country Coordination Group (European experts) Data on antimicrobial consumption in the primary care sector and in the hospital sector Annual report and interactive database (March 2013) http://ecdc.europa.eu/en/activities/surveillance/esac-net/pages/index.aspx

Consumption of antibiotics for systemic use (ATC group J01) in the community*; EU/EEA, 2010 *in Defined Daily Doses per 1000 inhabitants and per day Greece and Iceland: includes both community and hospital sector Spain: reimbursement data that do not include over-the-counter sales without a prescription Source: ESAC-Net, 2012 The symbols and indicate a continuous increase or decrease for the period 2008-2010, respectively. These trends were reported only for countries that consistently reported during 2008-2010.

Carbapenem consumption* (for the large majority in hospitals); EU/EEA, 2007 2010 2007 *in Defined Daily Doses per 1000 inhabitants and per day 2010 Source: ESAC-Net, 2012 The symbols and indicate a significant increase or decrease between 2007 and 2010, respectively. These trends are indicated only for countries that reported relevant data for both 2007 and 2010.

Healthcare-Associated Infections surveillance Network (HAI-Net) Since 2000, as the HELICS project and then the IPSE project, both financed by grants from the European Commission (DG SANCO) to Claude Bernard University Lyon I, France Coordinated by ECDC since July 2008 Coordination Groups (European experts) and contact points in participating countries Modules: Surgical site infections: 13 countries HAI in intensive care units: 14 countries Point prevalence survey: 30 countries HAI in long-term care (HALT-2, outsourced): 24 countries Reports http://ecdc.europa.eu/en/activities/surveillance/hai/pages/default.aspx

Modern medicine: not possible without effective antibiotics Hip / knee replacement Organ transplant Cancer chemotherapy Intensive care Care of preterm babies

Main actions to prevent and control antibiotic resistance New antibiotics (with a novel mechanism of action, research, development) Infection control (hand hygiene, screening, isolation) Prudent use of antibiotics (only when needed, correct dose, correct dose intervals, correct duration)

Eurobarometer Opinion Poll, November-December 2009 Antibiotics kill viruses. True or false? % respondents with correct answer (i.e., false ): 36% (range: 14 73%) 61 73% 41 60% 31 40% 21 30% 14 20% Source: Special Eurobarometer 338 / 72.5 Antimicrobial resistance, Nov.-Dec. 2009.

http://antibiotic.ecdc.europa.eu

European Antibiotic Awareness Day, 2008-2012 2008 2009 2010 2011 2012 Materials for the general public Materials for primary care prescribers Materials for hospital prescribers and hospitals Matched Get Smart week in the U.S. and the campaign in Canada Patient stories and Euronews movie 37 countries participated Collaboration with WHO/Europe 43 countries participated Matched campaigns in the U.S., Canada and Australia For more information: Earnshaw S, et al. Euro Surveill 2009;14(30) & http://antibiotic.ecdc.europa.eu

Malta

European Antibiotic Awareness Day: images from national campaigns on the prudent use of antibiotics

Toolkit for hospital prescribers: information materials Web banner Advertorial Fact sheet Check list PPT Presentation Screen saver European Antibiotic Awareness Day http://antibiotic.ecdc.europa.eu

http://antibiotic.ecdc.europa.eu

http://antibiotic.ecdc.europa.eu